IMPROVE-PD

Identification and Management of Patients at Risk – Outcome and Vascular Events in Peritoneal Dialysis. An EU funded consortium of 22 organisations (GA 812699)

[KDIGO @goKDIGO]

KDIGO invites you to share your feedback on the Scope of Work for the KDIGO Controversies Conference on Kidney Disease and Heart Failure. You can download the SOW and share comments via the feedback survey on the conference website through February 21: https://t.co/ISQlkWlFtq

This highly interactive conference will be co-chaired by @NishaKidneyDo and @lamcardio in March 2024 in Vancouver. The conference will bring together key thought leaders and relevant stakeholders in nephrology, cardiology, and related disciplines, as well as patients and caregivers, who will comprehensively review the literature and current state of understanding in this area and address clinical issues and controversies.

Following topical plenary presentations, four breakout groups will address pathophysiology, diagnosis, treatment, and clinical trials for patients with heart failure and kidney disease. Each group will cover all types of heart failure as well as all stages of kidney disease. The conference output will include the publication of a conference report that will help guide KDIGO and others on therapeutic management and future research.

KDIGO thanks you in advance for your help making this conference as useful as possible to clinicians and patients.

#CKD #CVD #heartfailure #kidneydisease

[IMPROVE-PD @ImprovePd]

Lessons from animal models: unraveling kidney fibrosis.
Read more here!:
Carnosinase-1 Knock-Out Reduces Kidney Fibrosis in Type-1 Diabetic Mice on High Fat Diet https://t.co/WPxPTd1lxo #mdpiantioxidants via @antioxidants_OA

[IMPROVE-PD @ImprovePd]

@DipakRamji5 Very interesting study, congrats to all the authors!

[Dipak Ramji PhD FLSW @DipakRamji5]

Great collaboration with Anne-Catherine Raby from the School of Medicine, Cardiff University!

Therapeutic targeting of Chronic Kidney Disease-associated DAMPs differentially contributing to vascular pathology https://t.co/RrH3JrP1Kw

[IMPROVE-PD @ImprovePd]

Targeting inflammation to treat diabetic kidney disease: the road to 2030

https://t.co/kuKzmHMmts

[Nature Rev Immunol @NatRevImmunol]

Anti-cytokine autoantibodies: mechanistic insights and disease associations https://t.co/GXYszzB4rQ

[Nature Reviews Nephrology @NatRevNeph]

The natural history of CKD and relationship to cell number and cell death.

https://t.co/NK11tBTqEZ

[Int. Soc. for Peritoneal Dialysis @ISPD1]

Reminder! The deadline to apply for the ISPD Fellowships is Sept 30th. You have still 2 weeks to select a destination, decide on a training program with your tutor, and submit a winning application. More information on https://t.co/Td2wVympB2 or DM us. Please share & retweet!

[World Congress of Nephrology @ISNWCN]

The #ISNFilmEvent jury will select 6 finalists from the submitted films. The winner(s) will be announced and awarded at the session “Kidney Stories From All Around the World” organized during the WCN'24 #ISNWCN.

Awards and Prizes:
🥇 “ISN Community Best Film”
The winner will receive complimentary registration to WCN’24 (payment refund) and a travel grant (complimentary registration and contribution to travel and accommodation) to attend the WCN’25.
🥇 “WKD Best Film”
The winner will receive complimentary registration to WCN’24 (payment refund).

[IMPROVE-PD @ImprovePd]

IMPROVE-PD Finder: A Web-Based Platform to Search and Share Peritoneal Dialysis Biobank, Registry, and Clinical Trial Metadata.
Kidney International Reports https://t.co/vbOZoMMxgF

[IMPROVE-PD @ImprovePd]

Read about the role of immune cells in the damage of the peritoneal membrane by repeated exposure to Peritoneal Dialysis fluids during kidney replacement treatments and infections. https://t.co/XmdpYM7SR3 #mdpiijms via @IJMS_MDPI

[Johann Bauersachs @JBauersachsMD]

Finally we have a class IA indication ✅ for #SGLT2 inhibitors in #HFpEF‼️
Do not miss the review on mechanisms in #EHJ

@ehj_ed @ESC_Journals @JavedButler1 @rudolf_deboer @ShelleyZieroth @TRassafMD @DavidDuncker @SamiraSoltaniMD @HFA_President @GiuseppeGalati_ @PCSchulzeMD

[NatRevRheumatol @NatRevRheumatol]

New content online! Innate immune memory in inflammatory arthritis https://t.co/kDNal8yjOW

[EU Science & Innovation 🇪🇺 @EUScienceInnov]

You've got a game-changing project that's been cooking all summer? Apply for the Industry 5.0 Award and let your innovation shine!

We look for EU-funded projects that contribute to a more resilient 💪, sustainable ♻️, and human-centric European Industry.

Deadline: 15 September

[European Research Executive Agency @REA_research]

🌃The #EuropeanResearchersNight is back on 2⃣9⃣/09!

👩‍🔬👨‍🔬 It will unite passionate #researchers from numerous #MSCA funded projects and #science enthusiasts in 26 countries across Europe & beyond!

See which #events are organised near you 👇
https://t.co/iSmfioBaq1

#HorizonEU

[Nature Reviews Nephrology @NatRevNeph]

New Review! Interorgan communication networks in the kidney–lung axis by Yohei Komaru, Yun Zhu Bai, Daniel Kreisel & Andreas Herrlich https://t.co/HiATJbHdTy

[ERA - European Renal Association @ERAkidney]

📣Registrations for the 7th EUROD Winter Meeting are now open!
📌Do not miss the chance to submit your abstract by November 15, 2023
📆See you in Leuven (Belgium) on January 17-19, 2024!
More info 👉 https://t.co/7S898NNj88

[European Society of Cardiology @escardio]

Friends,

If you liked our visual summaries for the #ESCCongress hot lines, you can find them here https://t.co/6DhRTbLSfg 🤗

[Jonathan Chávez @JonathanNefro]

El Axolotl tiene un riñón muy similar al del humano, a diferencia nuestra, gozan de la capacidad de regenerarlo posterior a un daño grave en solo 2 meses.

Aquí podríamos encontrar la forma de revertir la enfermedad renal crónica

Kidney Int 2023
doi: 10.1016/j.kint.2023.05.020

[Nature Reviews Nephrology @NatRevNeph]

Approved cell and gene therapies worldwide https://t.co/8LOSartq2Q